Filing Details

Accession Number:
0001144204-18-065170
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-18 16:59:49
Reporting Period:
2018-11-20
Accepted Time:
2018-12-18 16:59:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1680048 Mustang Bio Inc. MBIO Pharmaceutical Preparations (2834) 473828760
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1709485 Md Manuel Litchman 2 Gansevoort Street
9Th Floor
New York NY 10014
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-20 2,500 $3.89 2,500 No 4 P Direct
Common Stock Acquisiton 2018-11-21 5,000 $4.21 7,500 No 4 P Direct
Common Stock Acquisiton 2018-11-26 5,000 $3.87 12,500 No 4 P Direct
Common Stock Acquisiton 2018-12-04 7,500 $3.60 20,000 No 4 P Direct
Common Stock Acquisiton 2018-12-10 8,000 $3.35 28,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 20, 2018 was $3.8751 to $3.8951, the range of prices for the purchase transactions on November 21, 2018 was $4.1992 to $4.219, the range of prices for the purchase transactions on November 26, 2018 was $3.8696 to $3.8708 and the range of prices for the purchase transactions on December 10, 2018 was $ 3.34 to $ 3.3532. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.